Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections.
Yeon Ju LaHye Rim KimDong Hyun OhJin Young AhnYong Chan KimPublished in: Yonsei medical journal (2022)
Definitive therapy with beta-lactams in patients with MSSA BSI was associated with lower 28-day mortality compared to definitive therapy with glycopeptides.